HSPA9 and lip and oral cavity carcinoma: Although our in vitro experiments demonstrated that mortalin silencing inhibited key hallmarks of oral cancer, such as cell survival, proliferation, EMT, angiogenesis, migration, and invasion, these findings were based on two oral cancer cell lines.